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aBstRact Chagas disease is known to be the result of a complex set of bio-ecological 
and social determinants. The maximum incidence of the disease occurred between 1950 
and 1970, with a downward tendency observed in the following decades. Innumerable 
socio-cultural and political elements take part in the geographic expansion of the disease, 
the prevention of the disease and in the medical attention given those infected. Over the 
next decades a major reduction in transmission is expected, especially in the vector and 
transfusion routes, as a consequence of control-oriented programs and changes in the 
production system, in conjunction with urbanization processes and extensive anthropic 
actions in endemic areas. A reduction in morbidity is also expected, owing to better 
access to the health system and to medical advances. Nevertheless, Chagas disease will 
continue to have great importance in the next two to three decades, the main challenges 
being surveillance of disease transmission and the medical attention provided to infected 
individuals. A reduction in the visibility of the disease, with negative repercussions in the 
political priority given to medical attention and disease control, is also anticipated.
KEY WoRds Chagas Disease; Social Conditions; Epidemiology/trends.
REsUMEn La existencia de la enfermedad de Chagas humana se considera el resultado 
de un conjunto complejo de determinantes bioecológicos y sociales. Su cumbre de 
incidencia se produjo entre los años 1950 y 1970, observándose una tendencia a la 
disminución en las décadas siguientes. Innumerables elementos socioculturales y 
políticos están presentes también en la expansión geográfi ca de la enfermedad, en su 
prevención y en la atención médica a los infectados. Para las próximas décadas se espera 
una mayor reducción de la transmisión, especialmente vectorial y transfusional, como 
producto de las acciones de control y de los cambios en el sistema de producción, 
en paralelo con la urbanización y con las acciones antrópicas extensivas en las áreas 
endémicas. Se espera también una reducción en la morbilidad, dependiente de un mejor 
acceso a los sistemas de salud y de los constantes avances en la medicina. Sin embargo, 
la enfermedad seguirá siendo muy importante por dos o tres décadas más, dejando como 
principales desafíos la vigilancia sobre su transmisión y la atención a los individuos ya 
infectados. Está prevista una disminución en la visibilidad de la enfermedad, con refl ejos 
negativos en la prioridad política de las acciones sobre su atención y control.
paLaBRas cLavEs Enfermedad de Chagas; Condiciones Sociales; Epidemiología/
tendencias.
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intRodUction
Human Chagas disease (HCD) has existed in 
the New World for at least nine thousand years. It 
is a Latin American endemic entity derived from a 
much older wild enzootic disease, in which the pro-
tozoan Trypanosoma (Schizotrypanum) cruzi (T. 
cruzi) moves through different ecotopes, including 
arthropod vectors (Hemiptera, Reduviidae, Triato-
minae) and small mammals (1-5). The disease pos-
sesses social, economic and political determinants 
that depend, on the one hand, on human beings’ 
occupation of natural environments in pursuit of 
subsistence and wealth, and on the other hand, on 
poverty, anthropic activity and poor relationships 
of production (6). The disease has spread through 
internal population movements in Latin America, 
starting with the ancient migrations of indigenous 
peoples such as the Quechua, the Aztec and the 
Maya and intensifying during the post-Colombian 
European invasion (3,7). The socio-cultural 
and political bases of this expansion – closely 
linked to precarious rural housing – have been 
described by various authors (3,6,8,9). The epi-
demiological peak occurred early in the second 
half of the twentieth century, mainly affecting 
socially deprived populations in rural environ-
ments throughout the continent, from Mexico to 
Patagonia. Since then, changes in the production 
system, waves of urbanization and actions taken 
to control the disease (via its vector and trans-
fusion transmission routes) have reduced the in-
cidence, prevalence and sociomedical impact of 
the disease (2,10,11,12).
In this article some discernable trends or 
estimates of HCD for the next twenty years are 
explored, focusing particularly on social aspects 
associated with its production, expansion, medical 
management and control.
cURREnt pRoFiLE oF HUMan cHaGas 
disEasE and cHanGEs occURREd 
ovER tHE Last tHREE dEcadEs
The reduction in the incidence of HCD ob-
served in the early 2010s was mainly due to vector 
and blood bank controls that had been intensified 
since the 1970s in several endemic regions. Owing 
to this decline in the number of new cases as well 
as to the deaths of infected individuals (especially 
due to advanced chronic cardiopathy), there was 
a progressive reduction in prevalence in many 
regions (13,14); however, some areas of residual 
transmission remain in poor and uncontrolled 
(or insufficiently controlled) regions, for example 
in large areas of the South American Chaco and 
parts of Mexico. The two main transmitting vector 
species (Triatoma infestans and Rhodniusprolixus) 
have been virtually eliminated from many regions 
that formed part of the original distribution, while 
the proportion of blood banks under serological 
screening is above 95% in the majority of endemic 
countries. Furthermore, a reduction in congenital 
and transfusion-based transmission due to a de-
creasing frequency of infections, both in young 
pregnant women and blood donors, is currently 
observed. Similarly, in the last two decades, a de-
crease in HCD morbidity and mortality has been 
observed in many areas of the continent, especially 
in those that have transmission control and that 
offer better medical care coverage (14,15). Con-
versely, episodes of oral transmission have been 
observed in areas where wild triatomines live, 
especially in the Amazon region; these episodes 
range from 100 to 200 cases per year, although 
this is likely an underestimate. Another matter 
of concern is the intensified migration of chroni-
cally infected individuals from Latin America to 
non-endemic countries worldwide (2,12,15). In 
summary, the major epidemiological and sociopo-
litical changes occurring over the last two or three 
decades associated with HCD have been: the 
global evolution of the relationships and technol-
ogies of agricultural production, a strong urban-
industrial trend, intensification of rural to urban 
and international migrations, expansion of control 
programs and technical advances in the medical 
treatment of those infected. In this vein, Table 1 
shows some significant figures presented by Dr. 
Roberto Salvatella, including estimates by the Pan 
American Health Organization.
Currently, the distribution of HCD has been 
fundamentally reduced to the endemic areas, 
where mortality is still high. Moreover, it is esti-
mated that HCD prevalence does not exceed 7-8 
million infected individuals and that its incidence 
is even lower (14,19). In socioeconomic terms, 
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estimates by the World Bank have shown a sig-
nificant reduction in the productive days lost per 
year due to HCD between 1990 and 2007 (20).
The inherited and current challenges of HCD 
control are based in three pillars:
a. The implementation, expansion and streng-
thening of vector control programs in endemic 
countries, including sustainable epidemiolo-
gical surveillance (21).
b. The implementation, expansion and streng-
thening of control programs in blood banks, 
which should be adequately extended to non-
endemic countries to which infected indivi-
duals immigrate (12,22).
c. The provision of medical care and social security 
to all those infected, including medical exami-
nations (and treatment, if necessary) of children 
with seropositive mothers, even those from the 
most remote and isolated populations (2,23,24).
sociaL aspEcts oF HUMan cHaGas 
disEasE: ExpEctEd tREnds in tHE 
coMinG YEaRs
The most plausible timeframe for which to 
make future projections is over the next twenty to 
thirty years, considering pragmatically the natural 
history of the disease, the slow ecological, social 
and political changes occurring in endemic areas, 
the pace of scientific progress and the socio-political 
process of globalization (12,15). Traditional epide-
miological parameters (transmission, incidence, 
prevalence, morbidity and socio-medical burden of 
disease) will be employed for this reflection.
Vector transmission of HCD is closely con-
nected with the socio-cultural and political events 
of an endemic region (6,21). Its downward trend 
will continue due to control programs, extensive 
anthropic actions upon the environment, rural 
to urban migration and drastic changes in the ag-
ricultural production system. Nevertheless, the 
“vector/oral” routes will remain at their current 
levels in some areas (for example in the state of 
Pará in Brazil), and occasional cases may possibly 
appear in areas where wild triatomines are present 
(2,7). The primary human actions upon the envi-
ronment that concern HCD are monocultures, 
deforestation and the construction of roads, cities 
and hydroelectric plants, all of which lead to a de-
cline of native vectors in the natural environment 
(6,25). However, deforestation can at first function 
as a trigger for the invasion of artificial ecotopes 
by native species, primarily in search of food and 
shelter or attracted to the light, thus causing occa-
sional incidents of oral transmission dependent on 
the vector. The phenomenon of intra-domiciliary 
colonization of those species is now very rare, slow 
and dependent on bio-ecological characteristics, 
because of the general lack of long periods of time 
for their settlement or recovery (25,26,27). In this 
regard, the events that took place over the last forty 
years in the Brazilian Amazon are illustrative: a 
marked tendency towards internal migration and 
massive deforestation caused concern among sci-
entists and public health professionals about the in-
cidence of new cases of HCD in the region, caused 
by the domiciliation of native vectors and passive 
transportation of alien species, particularly T. in-
festans and T. brasiliensis (16,26,28). Fortunately, 
this is not the situation at present, owing to the 
ecological characteristics of the area and the low 
Table 1. Changes in the epidemiological parameters of Chagas disease in the 
Americas, in the years 1990, 2000 and 2006.
Epidemiological parameters 1990 2000 2006
Annual deaths >45,000 21,000 12,500
Cases of human infection 30 million 18 million 15 million
New cases per year 700,000 200,000 41,200
Population at risk 100 million 40 million 28 million
Distribution 21 countries 19 countries 18 countries
Source: Salvatella (18), using estimates by the Special Programme for Research and Training in Tropical Diseases (TDR), World Health 
Organization.
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ecological valence of native vectors (15,27,29,30). 
In turn, certain elements of social evolution such as 
the urbanization phenomenon, vector control pro-
grams and progressive rural housing improvements 
(for example, with the introduction of gas stoves) 
produced a substantial reduction of introduced 
and secondary species in the immediate human 
environment (10,31). Observing the significant in-
fluence that globalization and changes in the pro-
duction system have had on vector transmission, a 
recently published analysis highlights the following 
aspects (15):
  Deforestation resulting from a strong timber 
market, the expansion of agro-industries and 
the creation of new agricultural fronts in en-
demic areas.
  Extensive use of pesticides in modern agribu-
siness projects.
  Expansion of the use of electricity and industrial 
machinery, influencing the behavior of vectors 
and rural demographics.
  Progressive disappearance of natural reservoirs 
of the parasite as a result of deforestation, pesti-
cides and extensive monoculture.
  Changes in the model of production and a 
market dominated by economies of scale, 
giving priority to agribusiness rather than to the 
classic economic strategy.
  Implementation of modernization factors, es-
pecially automation, robotics and housing 
improvement.
The anthropic activity exerted upon the envi-
ronment tends to increase worldwide, with certain 
distinctive features in originally HCD-endemic 
areas (25,26). The searches for primary agricultural 
production and clean energy respond to urgent 
global needs that already affect and have growing 
significance in Latin America. Extensive food crop 
cultivation employing modern technology is pro-
gressing in poor and typically HCD-endemic areas 
such as the Brazilian Cerrado (coffee, sugar cane, 
and soy production, cattle ranching), the South 
American Chaco (soy and sugarcane production) 
and the arid Northeast of Brazil (sugarcane and 
fruit production). These activities require large 
foreign capital, force poor populations out of the 
area and reduce natural niches for vectors and res-
ervoirs. No trend towards subsistence or a return 
to the old model of family microeconomies is 
observed. Market demands and the political and 
economic determinants of globalization are the 
main reasons accounting for this process (15). The 
residual cases of vector transmission, as already 
mentioned, should decrease gradually, concen-
trating in poorer and more isolated regions of the 
continent, where HCD surveillance and control 
will remain dependent upon consistent and sus-
tained public policies (10,21). With regard to 
human dwellings hospitable to vector domicili-
ation and HCD transmission, there has been a pro-
gressive trend towards the disappearance of huts 
and shacks, primarily as a result of the processes 
of urbanization and modernization of agricultural 
production. This process will be slower in micro-
regions characterized by poverty such as the South 
American Chaco and the Northeast of Brazil. At 
the macro-political level, government programs 
for rural housing in most endemic areas are not ex-
pected to be further developed given the current 
trend towards urbanization, and political priorities 
in this regard are fundamentally linked to urban 
housing programs (32,33). At the epidemiological 
level, the primary residues of vectors tend to be 
concentrated in the peridomicile, which is more 
accessible to secondary native species and more 
difficult to control chemically (10,30). Keeping 
chickens is a common activity in rural areas, hen 
houses generally being the principal peridomi-
ciliary focus of triatomines. Therefore, the mass 
production of chickens in the context of global-
ization could result in a significant downward 
trend in the existence of hen houses in dwellings. 
The same applies to other domestic animals bred 
as a source of food for families, for example rabbits 
and guinea pigs (27,32).
When considering oral transmission, espe-
cially as a particular product resulting from the 
presence of infected vectors in the proximity of 
humans and their food, it is still impossible to 
predict a trend, although oral transmission is 
more concentrated in the Amazon region. None-
theless, a slowly decreasing trend can be noted 
insofar as the industrialization phenomena pro-
gresses and food preparation practices improve 
(2,17,29).
As regards transmission through transfusion, 
the trend is towards virtual elimination within the 
short- to medium-term. The basis for this trend is 
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the active serological screening of blood donors, 
which is improving and expanding worldwide 
and which is reinforced by the decreasing 
number of infected individuals (especially young 
people) entering into the donor system (7,10). In 
Brazil, for example, from an estimated 15,000 
cases of transmission through transfusion in the 
1970s, at present no more than 10 cases per year 
(3,22) may be expected. The time will come to 
make a decision at the socio-political and admin-
istrative level regarding the continuity of HCD 
serological screening in blood banks, as large 
amounts of money are spent on thousands and 
millions of tests only to find a minimum number 
of infected donors (3,10,11). However, control 
over transfusion-associated HIV infection will 
remain the primary argument for maintaining 
rigorous surveillance (both health and epide-
miological) of blood banks around the world, a 
practice that should continue for some decades 
and that benefits HCD control as well as syphilis 
and viral hepatitis control (11,22). In the socio-
medical arena, it is necessary to improve referral 
of seropositive subjects to a system trained in 
medical care for HCD, which does not happen 
on a regular basis everywhere, including non-
endemic countries (7,10,11,22).                           
Although the prevention of congenital 
transmission in medical terms is very complex, 
the trend is clearly towards its progressive 
elimination, in conjunction with the control of 
other forms of transmission. This can be seen 
in surveys of seroprevalence among pregnant 
women in areas with vector and transfusion 
control; seropositive residues are found only 
in women over the age of 30 years (10,34-36). 
Table 2 shows the incidence of congenital cases 
in Brazil in 2010.
These estimates (Table 2) are not far re-
moved from the actual situation in Brazil, as 
recent serological surveys of young children in 
the country have only exceptionally detected se-
ropositive individuals. For example, in the last 
national survey, carried out in children under 
five years of age, only 32 serum tests were 
positive (0.03%) out of the nearly 105,000 tests 
obtained nationwide; of these, a maximum of 
20 were cases attributable to congenital trans-
mission (36). From a health care perspective, few 
regular and sustained programs for the diagnosis 
and monitoring of mother-to-child transmission 
still exist that offer a real chance to cure infected 
newborns, with exceptions in Uruguay and some 
regions of Argentina, Paraguay and Brazil. For 
treatment to rely only on the clinical detection 
of congenital cases is highly ineffective in public 
health terms, given that most cases are asymp-
tomatic (7,35). As occurs with vector control, 
the tendency of health authorities is to invest 
less and less in health programs for congenital 
Chagas treatment in countries like Brazil, where 
its occurrence is minimal (15).
incidence and prevalence
Incidence and prevalence are parameters 
dependent on the transmission levels discussed 
Table 2. Estimate of the incidence of congenital human 
Chagas disease in Brazil in 2010.
Event Number %
Live births 2,920,603 100.00
Mothers aged 15-29a 2,587,477 88.60
Mothers aged 30-59b 332,831 11.40
Total seropositive mothers 7,837 0.27
Estimated risk of transmissionc - 0.60
Source: Own elaboration based on data from the Information Technology Department of the Sistema 
Unico de Saúde (DATASUS).
aEstimated infection 0.2%: 5,174 seropositive mothers
bEstimated infection 0.8%: 2,663 seropositive mothers
cYearly total of 47 cases.
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previously. The general trend is clearly regressive, 
remaining stable in locations lacking activities of 
control (10,24). Prevalence is additionally influ-
enced by mortality, which becomes more signifi-
cant as infected individuals age and die, including 
from many other chronic-degenerative causes 
(10,33,37-40).
Morbidity
Morbidity due to HCD refers mainly to the 
chronic phase, especially in terms of cardiopa-
thies (9,41,42). Up to 10% of acute patients may 
die if not treated promptly, the reason for which 
a quick diagnosis is required. In the treatment of 
acute patients a larger number of parasitological 
cures can be offered, which result in better patient 
prognosis in the long term (34). Individuals in the 
chronic phase usually benefit from good medical 
care (including specific treatment when indi-
cated), with both improved quality and increased 
quantity of life (9,11,34,42,43). All of these op-
tions presuppose existing medical care capabil-
ities, especially within endemic areas with active 
transmission, but unfortunately the situation is 
much more delicate. It is recognized that medical 
expertise regarding HCD in Brazil and other 
countries is decreasing and that medical schools 
are generally tending to reduce the amount of 
academic content on the disease included their 
curricula (15,44). Notwithstanding, in the course 
of overall medical development many drugs and 
diagnostic and therapeutic procedures employed 
in the treatment of other diseases have been ex-
ploited for HCD, particularly for treating chronic 
heart disease, thus enabling significant advances 
in the clinical management of HCD. Some note-
worthy examples include modern antiarrhythmics, 
defibrillators, angiotensin-converting enzyme in-
hibitors (ACE), modern surgical techniques applied 
to the digestive system, and increased medical in-
dications for specific treatment (2,23,43,45).
social and medical care
Chronically infected individuals suffering 
from cardiopathies or mega syndromes are the 
central problem in HCD medical care, because 
these individuals lose both quality and quantity 
of life. The vast majority of these individuals are 
poor and depend financially, intellectually and 
politically on government assistance for their sur-
vival and medical care (6,33). Key issues involved 
in the treatment of Chagas-infected individuals 
can be summarized as issues of access, coverage, 
expertise, adherence, referral and counter-re-
ferral (45). A general effort exists to improve the 
medical care given to infected individuals in en-
demic and non-endemic countries, with support 
from different agencies such as the World Health 
Organization (WHO), the Pan American Health 
Organization (PAHO), and Médecins Sans Fron-
tières (MSF). However, the training given to pro-
fessionals at universities is inadequate and there is 
a trend towards further reduction of such training 
because of the progressive lack of academic in-
terest in HCD (15). In particular, political and 
administrative aspects of national health systems 
have begun adopting different perspectives in the 
care of infected individuals (46). In broad terms, 
the trend towards health system decentralization, 
increasing urbanization and a relative increase 
in access to medical services by infected indi-
viduals can be regarded as positive events in 
the new millennium (15). In Brazil, for example, 
new social policies implemented during the last 
17 years are aimed at establishing an equitable 
universal health care system – the Unified Health 
System (SUS, from the Portuguese Sistema Único 
de Saúde) – which also offers drugs and proce-
dures free of charge to those who cannot afford 
them, such as the implantation of pacemakers, as 
well as benznidazole, amiodarone, diuretics and 
ACE inhibitors, among other drugs. Nonetheless, 
despite the improvements achieved thus far, the 
SUS needs to strengthen its capacity to provide 
quicker access and better counter-referrals and 
expertise, which requires government resolve 
and continued stimulation on the part of the sci-
entific community (33).
Macro-political aspects and the role of the 
scientific community
Taking into account its principal social and 
geographical characteristics, HCD can be con-
sidered a problem of the State, both in endemic 
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and in non-endemic regions. Disease control de-
pends on laws, political will and specific public 
health actions that should be adequate technically. 
Government actions based in the decentralization 
of health services and the progressive shrinking 
of the State – a distinctive feature of the last two 
decades – may turn out to be positive or negative 
factors in the fight against HCD, depending on 
their continuity and degree of coverage. However, 
the trend is to diminish or undermine actions of 
control due to lack of articulation, expertise and 
political priority placed on a poverty-related 
disease. Something similar happens in non-en-
demic countries, where the health care given 
to infected migrants is negatively influenced by 
their poverty and illegal immigration status (6,8). 
In this context, the classic approach adopted by 
the scientific communities dedicated to HCD is 
one of constant political appeals to their govern-
ments, often promoting supranational cooperation 
for disease control (intergovernmental initiatives) 
(33,46).
FinaL tHoUGHts
Within the economic, demographic and 
social epidemiological tendencies evolving over 
the coming decades, significant changes will con-
tinue to occur that will impact the disease. The dis-
placement of infected individuals to urban centers 
and non-endemic countries will remain stable for 
a few years, with a possible long-term downward 
trend. Key factors of these movements are the 
search for employment and the deterioration of 
older models of rural production. Insofar as rural 
depopulation continues and control programs 
advance, the flow of infected individuals will de-
crease (15). The decline in domiciled vectors and 
the controls of blood banks will reduce the trans-
mission and visibility of HCD, impairing in turn 
the priority given to control actions, a situation that 
will become more serious in emergency circum-
stances related to other endemic problems such 
as dengue, hantavirus, and influenza (6,15,20). 
Unfortunately, the educational support for actions 
of surveillance and control will gradually weaken 
and decrease its presence in endemic areas, so 
it will be increasingly difficult to include HCD 
in formal education syllabi in endemic countries 
(10,12,15). At the same time, because of the 
strong trend towards decentralization in national 
health systems, actions of control and surveillance 
must increasingly rely on local authorities, thereby 
depleting the central levels (33,46). All of this is 
already happening in Brazil, regrettably producing 
a loss of data and a flagrant decrease in national 
references (10,13,15). On the other hand, great 
social and political benefits stemmed from the 
aforementioned intergovernmental initiatives for 
disease control, initiatives which involved coun-
tries from the entire endemic region and which 
enabled scientific and technical improvements 
along with an effective political cooperation 
among those affected (12,32). All signs indicate 
that infected individuals will continue to be very 
poor, that they will be geographically isolated or 
migrants, often with illegal status, and that they 
will remain dependent on public health services. 
In terms of the scientific community committed 
to HCD control, the situation also indicates that 
the motivation and interest in further research will 
wane, and the social emphasis placed on this en-
demic disease will naturally decline within inter-
national development agencies such as the PAHO 
and the WHO. Despite all the advances, HCD 
will remain a very important social problem for 
the next twenty years or more, as well as a source 
of scientific and political growth among affected 
countries, with additional interest on the part of 
some potentially affected countries such as the US 
(15,33,44,46-48).
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